Tuesday, 19 Nov 2019

You are here

A Potential Biomarker for Chronic Fatigue Syndrome Patients

Myalgic encephalomyelitis/chronic fatigue syndrome affects at least 2 million people in the United States and bears tremendous overlap with fibromyalgia - both being difficult to diagnosis because the symptom complex is often unrecognized and these conditions have no biomarker test. 

A new report from Proceedings of the National Academy of Sciences  describes a new nanoelectronics assay designed to measure immune cells’ response to an osmotic stressor—salt. This approach was developed as a means of replicating postexertional malaise, the cardinal feature of chronic fatigue syndrome. 

Using blood samples from 40 control and severe chronic fatigue syndrome patients, they observed that the ME/CFS patients responses to hyperosmotic stressors yielded a larger change in the impedance pattern that was dramatically different from the response observed among the control samples.

These spikes in impedance could be an indication that the patients’ cells are straining to effectively maintain homeostatic equilibrium under stress, and may correlate with disease severity. 

Researchers intend to create a handheld diagnostic device that would use this assay, and artificial intelligence and machine learning algorithms, to better diagnose patients with chronic fatigue syndrome. 

The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

NIH Conference Review of Chronic Fatigue Syndrome

The current issue of JAMA reviews recent advances on chronic fatigue syndrome, also known as myalgic encephalomyelitis/(ME/CFS), based on a 2-day conference held at the NIH in an April 2019. The NIH 2-day conference reviewed recent progress and new research in several areas described below.

Study Looks at Opioid Use After Knee Surgery

A small study looked at whether reducing the number of opioid tablets prescribed after knee surgery would reduce postoperative use and if preoperative opioid-use education would reduce it even more.

Gabapentinoid Drugs Overuse and Misuse

A recent article in JAMA by Drs. Goodman and Brett reviews the increasing off label use of gabapentinoid drugs, originally developed as antiseizure drugs that are now increasingly prescribed for painful conditions.

Pilot Study Targets Insulin Resistence in Fibromyalgia

An unusual pilot study has shown that insulin resistence (IR), assessed by Hgb-A1c levels, was more prevalent in fibromyalgia (FM) patients compared to non-diabetic controls and that when FM patients were given metformin, half had complete resolution of their pain.

Sleep Myths Debunked

A panel of 10 sleep experts studied 20 common sleep myths and found little or no evidence in support of these beliefs.

Sleep issues are highly prevalent among US adults, but few admit to it or do anything to manage it.